Baricitinib (LY3009104, INCB028050) 50mg | 98.06%
APEXBIO TECHNOLOGY LLC
JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050)
Search Results
Baricitinib (LY3009104, INCB028050) 200mg | 98.06%
APEXBIO TECHNOLOGY LLC
JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050)
CYT387 10mM (in 1mL DMSO) | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387
CYT387 Evaluation Sample | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387
CYT387 5mg | 98.7%
APEXBIO TECHNOLOGY LLC
CYT387
Baricitinib (LY3009104, INCB028050) 10mg | 98.06%
APEXBIO TECHNOLOGY LLC
JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050)
Baricitinib (LY3009104, INCB028050) 5mg | 98.06%
APEXBIO TECHNOLOGY LLC
JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050)
Baricitinib (LY3009104, INCB028050) 10mM (in 1mL DMSO) | 98.06%
APEXBIO TECHNOLOGY LLC
JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK
More Information Supplier PageBaricitinib (LY3009104, INCB028050)
WP1066 25mg | 99.84%
APEXBIO TECHNOLOGY LLC
WP1066
WP1066 10mg | 99.84%
APEXBIO TECHNOLOGY LLC
WP1066